Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Prothena Corporation PLC - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
PRTA
Nasdaq
8731
https://www.prothena.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Prothena Corporation PLC
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
- Mar 28th, 2024 12:00 pm
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
- Mar 26th, 2024 3:21 pm
Prothena to Participate in Upcoming Healthcare Conferences
- Mar 5th, 2024 9:05 pm
Prothena Appoints David Ford to Newly Created Chief People Officer Position
- Mar 4th, 2024 9:05 pm
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate
- Feb 21st, 2024 9:05 pm
Prothena Full Year 2023 Earnings: Beats Expectations
- Feb 17th, 2024 12:45 pm
Prothena (PRTA) Q4 Earnings Miss Estimates on Higher R&D Expense
- Feb 16th, 2024 6:33 pm
Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript
- Feb 16th, 2024 3:33 pm
Prothena Corp PLC (PRTA) Reports 2023 Financial Results and Provides 2024 Outlook
- Feb 15th, 2024 9:48 pm
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
- Feb 15th, 2024 9:05 pm
Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
- Feb 8th, 2024 9:05 pm
Arvinas, Inc. (ARVN) Soars 10.0%: Is Further Upside Left in the Stock?
- Feb 2nd, 2024 7:59 am
Prothena Corp PLC Chief Accounting Officer Sells 5,000 Shares
- Jan 25th, 2024 4:02 am
Prothena's (PRTA) Update on Pipeline Progress Disappoints
- Jan 10th, 2024 5:06 pm
Prothena (PRTA) Surges 12.3%: Is This an Indication of Further Gains?
- Jan 10th, 2024 10:38 am
Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs
- Jan 8th, 2024 1:30 pm
Prothena Corp PLC Chief Accounting Officer Sells Company Shares
- Dec 21st, 2023 2:01 pm
These 3 Biotech Stocks Have Strong Upside Potential, Says Deutsche Bank
- Dec 17th, 2023 10:41 am
The Zacks Analyst Blog Highlights Biogen, Prothena, AC Immune's and Vaxxinity
- Dec 12th, 2023 2:10 pm
Alzheimer's Disease Space Evolves in 2023: Stocks in Focus
- Dec 11th, 2023 2:06 pm
Scroll